Physician

David James Thomason, M.D.

According to 2025 Medicare claims, David Thomason, M.D. (NPI: 1770878373) practices physical medicine and rehabilitation in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is RESTORATION HEALTH OF SOUTH ALABAMA, INC (NPI: 1609391853; TIN: 82-1803192) and primary practice location at 36527-5672.

Thomason's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 53,819 HCPCS/CPT codes, and received $510,419 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 14,487 prescription claims across 1,378 beneficiaries totaling $520,207 in drug costs, led by Relistor (Methylnaltrexone Bromide). 2021 DME data shows 36 claims. Open Payments data shows 48 records totaling $784. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $76,197 to $510,419. Similarly, Part D prescription costs have risen steadily, from $25,136 to $520,207. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,889 and ending at $685.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	234	1,679	$76,197
2016	439	3,636	$248,463
2017	569	4,994	$309,818
2018	612	5,270	$366,523
2019	729	7,517	$497,062
2020	870	7,338	$497,708
2021	996	9,422	$568,767
2022	961	9,070	$528,511
2023	1,003	8,290	$557,130
2024	919	53,819	$510,419

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	233	497	$25,136
2016	381	1,341	$72,016
2017	540	2,568	$99,264
2018	654	4,008	$207,333
2019	866	5,219	$245,308
2020	891	5,497	$198,865
2021	1,143	8,519	$298,486
2022	1,150	11,858	$436,446
2023	1,266	14,161	$488,790
2024	1,378	14,487	$520,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	61	$1,003
2017	N/R	N/R	N/R
2018	N/R	34	$742
2019	N/R	12	$454
2020	N/R	24	$936
2021	N/R	36	$2,477
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	184	284	$200
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	690	1,769	$84
80307	Testing for presence of drug, by chemistry analyzers	193	230	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	406	663	$12
J1010	Injection, methylprednisolone acetate, 1 mg	385	46,396	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Relistor	Methylnaltrexone Bromide	41	1,143	$88,487
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,844	74,798	$59,087
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,711	45,906	$48,817
Movantik	Naloxegol Oxalate	92	2,760	$37,396
Lidocaine	Lidocaine	305	9,634	$35,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$784	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David James Thomason, M.D.?

Tedicare shows public-source Medicare data for David James Thomason, M.D. (NPI 1770878373), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David James Thomason, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David James Thomason, M.D.?

David James Thomason, M.D. is linked to RESTORATION HEALTH OF SOUTH ALABAMA, INC (billing NPI 1609391853) in the available physician profile data.

Does David James Thomason, M.D. have Open Payments data?

David James Thomason, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.